Back to KRYS
GOLDMAN SACHS GROUP INC → KRYS
GOLDMAN SACHS GROUP INC KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
21
Latest value
$381K
Q2 2026
Peak value
$65.9M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $65.9M |
| Q2 2025 | $7M |
| Q3 2025 | $50.4M |
| Q3 2025 | $11.1M |
| Q4 2025 | $210K |
| Q4 2025 | $234K |
| Q4 2025 | $25M |
| Q4 2025 | $46.9M |
| Q4 2025 | $46.9M |
| Q4 2025 | $25M |
| Q4 2025 | $234K |
| Q4 2025 | $210K |
| Q1 2026 | $26.9M |
| Q1 2026 | $28.2M |
| Q1 2026 | $257K |
| Q1 2026 | $222K |
| Q2 2026 | $59.4M |
| Q2 2026 | $50.5M |
| Q2 2026 | $316K |
| Q2 2026 | $433K |
| Q2 2026 | $381K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $381K | 1.0K | — | — |
| Q2 2026 | $433K | 1.2K | — | — |
| Q2 2026 | $316K | 850 | — | — |
| Q2 2026 | $50.5M | 135.9K | — | — |
| Q2 2026 | $59.4M | 159.9K | — | — |
| Q1 2026 | $222K | 858 | — | — |
| Q1 2026 | $257K | 993 | — | — |
| Q1 2026 | $28.2M | 109.0K | — | — |
| Q1 2026 | $26.9M | 104.1K | — | — |
| Q4 2025 | $210K | 851 | — | — |
| Q4 2025 | $234K | 950 | — | — |
| Q4 2025 | $25M | 101.4K | — | — |
| Q4 2025 | $46.9M | 190.3K | — | — |
| Q4 2025 | $46.9M | 190.3K | — | — |
| Q4 2025 | $25M | 101.4K | — | — |
| Q4 2025 | $234K | 950 | — | — |
| Q4 2025 | $210K | 851 | — | — |
| Q3 2025 | $11.1M | 63.0K | — | — |
| Q3 2025 | $50.4M | 285.2K | — | — |
| Q2 2025 | $7M | 50.8K | — | — |
| Q2 2025 | $65.9M | 479.6K | — | — |
Other funds holding KRYS
$537.3M
$502.2M
$502.2M
$339.5M